Target Name: SLC38A6
NCBI ID: G145389
Review Report on SLC38A6 Target / Biomarker Content of Review Report on SLC38A6 Target / Biomarker
SLC38A6
Other Name(s): NAT-1 | Probable sodium-coupled neutral amino acid transporter 6 | N-system amino acid transporter 1 | Solute carrier family 38, member 6 (SLC38A6) | solute carrier family 38 member 6 | N system amino acid transporter NAT-1 | Sodium-coupled neutral amino acid transporter 6 | Probable sodium-coupled neutral amino acid transporter 6 (isoform 1) | SNAT6 | Solute carrier family 38 member 6, transcript variant 1 | Na(+)-coupled neutral amino acid transporter 6 | Solute carrier family 38 member 6 | SLC38A6 variant 1 | S38A6_HUMAN

SLC38A6: A Protein Involved in Various Physiological Processes

SLC38A6 (NAT-1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the Na+/K+-ATPase (NAT) family, which is a transmembrane protein that plays a crucial role in maintaining the resting membrane potential of cells. SLC38A6 is also known as NSP46, and it has been shown to be involved in a variety of physiological processes in the body, including cell signaling, neurotransmission, and stress response.

One of the key functions of SLC38A6 is its role in generating action potentials, which are the electrical signals that are generated by the rapid depolarization of the neuronal membrane during the initiation of an action potential. SLC38A6 is involved in the regulation of the Na+ and K+ channels that are responsible for generating these signals, and it has been shown to play a critical role in the maintenance of the resting membrane potential of neurons.

In addition to its role in generating action potentials, SLC38A6 is also involved in the regulation of ion channels that are involved in neurotransmission. SLC38A6 has been shown to interact with several different neurotransmitter receptors, including N-methyl-D-aspartate (NMDA), dopamine, and GABA. These interactions are important for the regulation of neural communication and the modulation of neural activity.

SLC38A6 is also involved in the regulation of stress response, and it has been shown to play a critical role in the stress-induced increase in the activity of the neurotransmitter acetylcholine. This increase in neurotransmitter activity is important for the regulation of learning and memory, and it is thought to contribute to the stress-induced enhancement of neural activity that is observed in response to stress.

SLC38A6 is also involved in the regulation of cell signaling, and it has been shown to play a role in the regulation of cell proliferation and differentiation. SLC38A6 has been shown to interact with several different transcription factors, including DNMTAT, p300, and NF-kappa-B. These interactions are important for the regulation of gene expression and for the maintenance of cellular homeostasis.

In conclusion, SLC38A6 is a protein that is involved in a variety of physiological processes in the body. Its role in the regulation of action potentials, neurotransmission, stress response, and cell signaling is important for the proper functioning of the body and for the maintenance of cellular homeostasis. As a potential drug target or biomarker, SLC38A6 is a promising target for the study of a variety of neurological and psychiatric disorders. Further research is needed to fully understand the role of SLC38A6 in the regulation of cellular processes and to develop effective treatments for the disorders that are associated with its dysfunction.

Protein Name: Solute Carrier Family 38 Member 6

Functions: Probable sodium-dependent amino acid/proton antiporter, could be a neuronal transporter for glutamate

The "SLC38A6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC38A6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SLC38A7 | SLC38A8 | SLC38A9 | SLC39A1 | SLC39A10 | SLC39A11 | SLC39A12 | SLC39A13 | SLC39A14 | SLC39A2 | SLC39A3 | SLC39A4 | SLC39A5 | SLC39A6 | SLC39A7 | SLC39A8 | SLC39A9 | SLC3A1 | SLC3A2 | SLC40A1 | SLC41A1 | SLC41A2 | SLC41A3 | SLC43A1 | SLC43A2 | SLC43A3 | SLC44A1 | SLC44A2 | SLC44A3 | SLC44A3-AS1 | SLC44A4 | SLC44A5 | SLC45A1 | SLC45A2 | SLC45A3 | SLC45A4 | SLC46A1 | SLC46A2 | SLC46A3 | SLC47A1 | SLC47A1P2 | SLC47A2 | SLC48A1 | SLC49A3 | SLC49A4 | SLC4A1 | SLC4A10 | SLC4A11 | SLC4A1AP | SLC4A2 | SLC4A3 | SLC4A4 | SLC4A5 | SLC4A7 | SLC4A8 | SLC4A9 | SLC50A1 | SLC51A | SLC51B | SLC52A1 | SLC52A2 | SLC52A3 | SLC5A1 | SLC5A10 | SLC5A11 | SLC5A12 | SLC5A2 | SLC5A3 | SLC5A4 | SLC5A4-AS1 | SLC5A5 | SLC5A6 | SLC5A7 | SLC5A8 | SLC5A9 | SLC66A1 | SLC66A1L | SLC66A2 | SLC66A3 | SLC6A1 | SLC6A1-AS1 | SLC6A10P | SLC6A10PB | SLC6A11 | SLC6A12 | SLC6A13 | SLC6A14 | SLC6A15 | SLC6A16 | SLC6A17 | SLC6A18 | SLC6A19 | SLC6A2 | SLC6A20 | SLC6A3 | SLC6A4 | SLC6A5 | SLC6A6 | SLC6A7 | SLC6A8